It’s very difficult to understand the retinal structure of children because they are known to be uncooperative during eye examinations designed for adults. Baylor research, published in JAMA Ophthalmology, explores a new non-invasive technology that’s kind of like a handheld CT scanner for the eye.
Baylor Research Institute investigators found that the lipoprotein LOX-1 promotes humoral responses, which could allow researchers to design effective vaccines against microbial infections.
Baylor Research Institute (BRI), the research arm of the Baylor Scott & White Health, announced that it has signed an agreement with Swedish Orphan Biovitrum AB (Sobi) to non-exclusively license Baylor’s patents pertaining to the treatment of Systemic Onset Juvenile Idiopathic Arthritis.
Despite the availability of many medications, doctors have very little information about the best way to treat diabetes. However, a new study involving Baylor’s endocrinology team could give more insights and provide better options for diabetes management.
A common drug used to clean a person’s bowels before a colonoscopy could become the future standard of care for patients with acute hepatic encephalopathy (HE), a mental disorientation problem that affects up to one in two cirrhosis patients. The finding comes from new research, known as the “HELP Clinical Trial,” that appeared in JAMA Internal Medicine on Sept. 22.
People often think of physical therapy as a little bit of exercise to build up strength after knee surgery, or to relieve pain from a sore back. Others see it as an important bridge between serious, debilitating illness and an independent life.
Many believe that restrictive visitation policies affect the standard of care patients receive. Now, retrospective research from a team of Baylor nurses proves it.
Cardiologists on the medical staff at Baylor Jack and Jane Hamilton Heart and Vascular Hospital today implanted an investigational cardiac pacemaker the size of a multivitamin. The first implantable pacemakers, developed in the late-1950s, were nearer the size of a transistor radio.
As Baylor Scott & White Health marks the first anniversary of its merger, the organization has achieved the major goals established after becoming the largest not-for-profit health system in Texas in October 2013.
Thanks to new insights related to dendritic cell vaccines, researchers are investigating a potential vaccine for MS treatment and prevention at the Baylor Institute for Immunology Research (BIIR), a division of Baylor Research Institute. If future research supports early findings, the study could mark an important first in that it attacks MS early while preserving the immune system.
Recent Baylor Research Institute research shows that significant consumption of instant noodles – ramen included – may increase a person’s risk for cardiometabolic syndrome, especially in women.
New research from the Baylor Institute for Health Care Research and Improvement showed that a hospital’s commitment to implementing best practices significantly improves the quality of care it provides its patients. The study’s findings, which were e-published in the Journal of the American College of Surgeons, sheds new light on the life-or-death importance of following best practices.
New research from the Motion and Sports Lab at Baylor University Medical Center in Dallas may give children with cerebral palsy better treatment options in the future – and it all starts with looking at how cerebral palsy patients move compared to their peers.
Arti Lal, MD, a pediatrician who specializes in treating patients at the ADHD Clinic at Scott & White in North Austin, is currently utilizing a new technology on patients which is called the Quotient® ADHD Test. It is FDA-cleared for the objective measurement of hyperactivity, impulsivity and inattention, as an aid in the assessment of ADHD.
Approximately five million Americans suffer from hernias, according to the National Center for Health Statistics. Hernia surgery is often performed with minimally invasive techniques, which means patients can return quickly to normal activity with less discomfort and faster recovery. Scott & White Hospital – Round Rock has opened a Comprehensive Hernia Center for patients with mild to severe hernias looking for minimally-invasive treatment options. The new center offers the patient multi-disciplinary, integrated medical care in one location, which means access to in-house cardiology, pulmonology, endocrinology, Thoracic Surgery and Plastic Surgery.
Baylor Research Institute has received a $3.3 million grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), one of the National Institutes of Health, to fund its Autoimmunity Center of Excellence. The grant is awarded to Virginia Pascual, MD, the leader of the Autoimmunity Center of Excellence and a director at Baylor Institute for Immunology Research (BIIR).
For the first time, a minimally invasive transcatheter valve – tested by Baylor Research Institute in Dallas (BRI) – has been shown to save more lives than open-heart surgery, according to new research revealed at the American College of Cardiology’s 2014 Scientific Sessions and published in The New England Journal of Medicine.
Baylor Research Institute has been awarded a patent from the U.S. Patent Office for a potential strategy to improve the outcomes of islet cell transplantation for patients with type 1 diabetes and chronic pancreatitis.
Baylor Health Care System is bringing neurologic stroke expertise to its community-based medical centers via a portable robot communication system or telemedicine. Neuro-hospitalists based at Baylor University Medical Center in Dallas use iPads or laptop computers to connect with other Baylor medical centers whenever a call comes from their emergency departments.
Investigators with Baylor Research Institute, a research arm of Baylor Scott & White Health, have opened participation for a new clinical trial that could determine whether a certain blood test can detect colon cancer before it even develops.
A special newly discovered biomarker, “Gb3,” potentially related to the survival of heart disease patients, could change the way the country’s No. 1 killer is monitored in the future.
With one heartbeat, within one second, cardiologists can get an entire 3-D image of the heart that allows them to look at arteries and heart anatomy with excellent detail and with less medical radiation.
For patients recovering from a traumatic brain injury (TBI), the rehabilitation process – compensating for changes in functioning, adaptation and even community reintegration – can be challenging. Unfortunately, not all rehab programs are created equal, and with the differences comes a difference in outcomes, according to a first-of-its-kind study published in The Journal of Head Trauma Rehabilitation.
The Heart Hospital Baylor Plano became the first in the nation to treat a patient with the catheter-based SAPIEN 3 heart valve using the transapical approach (through the ribs). This new phase of a clinical trial, also known as Partner II, may offer older patients with inoperable heart valve conditions a second chance at life.
The survival rate for individuals who experience a sudden cardiac arrest outside of a hospital is a mere five percent. Time is crucial. Chances of survival drop by 10 percent for every minute that passes without someone performing cardiopulmonary resuscitation (CPR) or using an automated external defibrillator (AED).
This book offers practical strategies and lessons for other organizations in the areas of people, culture, and processes that have contributed to dramatic improvements in patient and operational outcomes at Baylor Health Care System.
Baylor Research Institute, the research arm of Baylor Health Care System, announced that it has signed an agreement with Novartis to non-exclusively license Baylor’s patents pertaining to the treatment of Systemic Onset Juvenile Idiopathic Arthritis (SJIA, or SOJIA) using interleukin-1 beta antagonists.
Robert Stoler, MD, FACC, FSCAI, director of the Cardiac Catheterization Lab at Baylor Heart and Vascular Hospital (BHVH) and co-medical director, Division of Cardiology, is leading Baylor’s participation in an exciting clinical trial to research a new treatment option for AS patients.
Baylor Endocrine Center is looking for volunteers to take part in a study to compare the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication for treating type 2 diabetes. The project is called the GRADE: Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study.
The general training program used by most cardiac rehabs follows national guidelines but these programs often do not meet the various physical requirements of specific workplaces.
Research utilizing a systems approach demonstrates that different vaccines lead to immunity via distinct immune response pathways. Published findings include interactive figures linked to the underlying data allowing readers seamless access to investigate new hypotheses.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, and TikoMed AB announced today that an agreement has been established to investigate TikoMed´s product IBsolvMIR® in a phase II clinical trial.
Fifteen-year-old Emily Castle isn’t your typical teen-ager. Plagued by health issues all her life, by the time she was just 13 she was experiencing headache pain severe enough to send her home from school.
Ten years ago in 2002, Baylor All Saints Medical Center at Fort Worth performed its first kidney transplant with a surgical team led by Marlon Levy, MD, surgical director, transplantation, Baylor All Saints.
The Symplicity trial tests a minimally invasive procedure - renal denervation. The experimental procedure uses heat that is generated by radio frequency to disrupt nerve communication to and from the kidneys. This can reduce overactivity in the sympathetic nervous system.
Baylor Institute for Rehabilitation (BIR) has received a $2.2 million grant extending for another five years the institute’s designation as a National Institute on Disability and Rehabilitation Research Model System site for traumatic brain injury.
An estimated 2.5 million Americans suffer from irregular heartbeats-also known as atrial fibrillation. The incidence of this potentially life changing cardiovascular condition is on the rise and expected to more than double by 2050.
Atrial fibrillation is a common complication of cardiac surgery, occurring in 10 percent to 40 percent of patients. Recent studies show it to be associated with poorer health following surgery and poorer long-term survival.
THE HEART HOSPITAL Baylor Plano became the first hospital in the world on Friday to merge two highly advanced technologies for atrial fibrillation therapy.
A new nationwide research initiative has been launched to define changes in the human immune system’s response to infection and vaccination using human rather than animal models, which could lead to better vaccines and other treatments. Baylor Research Institute (BRI), along with five other U.S.-based Human Immune Phenotyping Centers, will receive a total of $100 million over five years to conduct the research.
Even in an economy that's proved devastating to charitable giving and government grants, the Baylor Institute of Immunology Research (BIIR), a component of Baylor Research Institute (BRI), has managed to buck the trend: BIIR received grants totaling nearly $35 million in 2009.
Baylor Health Care System announced today the opening of a new Diabetes Health and Wellness Institute in an underserved community in South Dallas that it believes will ultimately influence the way diabetes is treated and prevented around the country.
Officials announced today that Baylor Research Institute (BRI), part of the Baylor Health Care System, was recently re-accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP). The re-accreditation certifies that BRI maintains efficient systems for monitoring research participant safety and embraces ethical standards higher than required by law in order to protect human participants participating in BRI research programs.
Antitope Ltd. announced today a research grant with Agence Nationale de Recherches sur le SIDA et les hepatitives virales (ANRS, France), INSERM (France) and Baylor Research Institute (BRI, Dallas) for the generation of multiple humanized antibodies.
Baylor Health Care System’s website – BaylorHealth.com—took home the gold at the thirteenth annual Healthcare Internet Conference and silver at this year’s W3 Awards.